Inflammation induces TDP-43 mislocalization and aggregation

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Correia, Ana Sofia ^a   Patel, Priyanka ^b   Dutta, Kallol ^b   Julien, Jean Pierre ^b  

^a LAVAL UNIVERSITY   (Canada)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; TAR DNA BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN; PROTEIN AGGREGATE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE CULTURE; CONTROLLED STUDY; CYTOPLASM; DEGENERATIVE DISEASE; DISEASE EXACERBATION; HUMAN; INFLAMMATION; MICROGLIAL CELL CULTURE; MOTONEURON; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; SPINAL CORD MOTONEURON; TDP 43 PROTEINOPATHY; ANIMAL; ASTROCYTE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MICROGLIA; POINT MUTATION; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, TRANSGENIC; MICROGLIA; POINT MUTATION; PROTEIN AGGREGATES; RNA, MESSENGER;

EID: 84948696711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140248     Document Type: Article

References (37)

1. Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 124(3):339-52. doi: 10.1007/s00401-012- 1022-4 PMID: 22903397
2. Morris HR, Waite AJ, Williams NM, Neal JW, Blake DJ. Recent advances in the genetics of the ALSFTLD complex. Curr Neurol Neurosci Rep. 12(3):243-50. doi: 10.1007/s11910-012-0268-5 PMID: 22477152
3. Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin JE et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain. 1991; 114 (Pt 2):775-88.
4. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al. TDP-43 is a component of ubiquitinpositive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351(3):602-11. S0006-291X(06)02318-7 [pii] doi: 10.1016/j. bbrc.2006.10.093 PMID: 17084815
5. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP- 43. Acta Neuropathol. 2007; 113(5):521-33. doi: 10.1007/s00401-006-0189-y PMID: 17219193
6. Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin VM et al. TDP- 43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol. 2007; 66(3):177-83. doi: 10.1097/01.jnen.0000248554.45456. 5800005072-200703000-00002 [pii]. PMID: 17356379
7. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314(5796):130-3. 314/5796/130 [pii] doi: 10.1126/science.1134108 PMID: 17023659
8. Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007; 61(5):427-34. doi: 10.1002/ana.21147 PMID: 17469116
9. Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010; 9(10):995-1007. S1474-4422(10)70195-2 [pii] doi: 10. 1016/S1474-4422(10)70195-2 PMID: 20864052
10. Daoud H, Valdmanis PN, Kabashi E, Dion P, Dupre N, CamuWet al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet. 2009; 46(2):112-4. jmg.2008.062463 [pii] doi: 10.1136/jmg.2008.062463 PMID: 18931000
11. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008; 63(4):535-8. doi: 10.1002/ana.21344 PMID: 18288693
12. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008; 40 (5):572-4. ng.132 [pii] doi: 10.1038/ng.132 PMID: 18372902
13. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008; 319(5870):1668-72. 1154584 [pii] doi: 10.1126/ science.1154584 PMID: 18309045
14. Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008; 7(5):409-16. S1474-4422(08)70071-1 [pii] doi: 10.1016/S1474-4422(08)70071-1 PMID: 18396105
15. Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol. 2009; 65(4):470-3. doi: 10. 1002/ana.21612 PMID: 19350673
16. Yokoseki A, Shiga A, Tan CF, Tagawa A, Kaneko H, Koyama A et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol. 2008; 63(4):538-42. doi: 10.1002/ana.21392 PMID: 18438952
17. Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. 2012; 13(1):38-50. nrn3121 [pii] doi: 10.1038/nrn3121
18. Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001; 276(39):36337-43. doi: 10.1074/jbc.M104236200M104236200 [pii]. PMID: 11470789
19. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem. 2005; 280(45):37572-84. M505557200 [pii] doi: 10.1074/jbc.M505557200 PMID: 16157593
20. Geser F, Lee VM, Trojanowski JQ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology. 2010; 30(2):103-12. NEU1091 [pii] doi: 10.1111/j.1440-1789.2009.01091.x PMID: 20102519
21. Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, Strong MJ et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol. 2011; 122(6):657-71. doi: 10.1007/s00401-011-0913-0 PMID: 22105541
22. Swarup V, Audet JN, Phaneuf D, Kriz J, Julien JP. Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis. J Neurosci. 2012; 32(50):18186-95. 32/50/18186 [pii] doi: 10.1523/JNEUROSCI.2267-12.2012 PMID: 23238732
23. Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J Exp Med. 2011; 208 (12):2429-47. jem.20111313 [pii] doi: 10.1084/jem.20111313 PMID: 22084410
24. Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011; 10(3):253-63. S1474-4422(11)70015-1 [pii] doi: 10.1016/ S1474-4422(11)70015-1 PMID: 21349440
25. Nguyen MD, Julien JP, Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci. 2002; 3(3):216-27. doi: 10.1038/nrn752nrn752 [pii]. PMID: 11994753
26. Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006; 52(1):39-59. S0896-6273(06)00725-2 [pii] doi: 10.1016/j.neuron.2006.09. 018 PMID: 17015226
27. Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S et al. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2011; 230(1-2):114-23. S0165-5728(10)00376-0 [pii] doi: 10.1016/j.jneuroim.2010.08.012 PMID: 20884065
28. Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol.2009; 206 (1-2):121-4.S0165-5728(08)00421 [pii] doi: 10.1016/j.jneuroim.2008.09.017 PMID: 19013651
29. Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain. 2011; 134(Pt 9):2610-26. awr159 [pii] doi: 10.1093/brain/awr159
30. Devon RM. Elimination of cell types from mixed neural cell cultures. In: Fedoroff S, Richardson A., editor. Protocols for Neural Cell Culture. Third Eddition ed. Totowa, New Jersey: Humana Press; 2001. p. 325-32.
31. Hart MP, Gitler AD. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J Neurosci. 2012; 32(27):9133-42. 32/27/ 9133 [pii] doi: 10.1523/JNEUROSCI.0996-12.2012 PMID: 22764223
32. Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL. Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis. 2010; 40(2):404-14. S0969-9961(10)00213-5 [pii] doi: 10.1016/j.nbd.2010.06.017 PMID: 20621187
33. Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2010; 107(8):3858-63. 0912417107 [pii] doi: 10.1073/pnas.0912417107 PMID: 20133711
34. Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci. 2010; 30(32):10851-9. 30/32/10851 [pii] doi: 10.1523/JNEUROSCI.1630-10. 2010 PMID: 20702714
35. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009; 106(44):18809-14. 0908767106 [pii] doi: 10.1073/pnas.0908767106 PMID: 19833869
36. Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP- 43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci. 2010; 30(2):639-49. 30/2/639 [pii] doi: 10.1523/JNEUROSCI.4988-09.2010 PMID: 20071528
37. Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, Tripathy K, Kwong LK, Trojanowski JQ, Lee VM. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015 Jul 22.